Universität zu Köln

Scheid, Christof (2016). ENDEAVOR to change treatment for multiple myeloma? Lancet Oncol., 17 (1). S. 2 - 4. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Scheid, Christof UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-292066
DOI:	10.1016/S1470-2045(15)00531-8
Journal or Publication Title:	Lancet Oncol.
Volume:	17
Number:	1
Page Range:	S. 2 - 4
Date:	2016
Publisher:	ELSEVIER SCIENCE INC
Place of Publication:	NEW YORK
ISSN:	1474-5488
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language PHASE-III TRIAL; DEXAMETHASONE COMBINATION; BORTEZOMIB; LENALIDOMIDE; CYCLOPHOSPHAMIDE; TRANSPLANTATION; MULTICENTER; INDUCTION Multiple languages Oncology Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/29206